Search

Your search keyword '"Loussouarn, Delphine"' showing total 287 results

Search Constraints

Start Over You searched for: Author "Loussouarn, Delphine" Remove constraint Author: "Loussouarn, Delphine" Publication Year Range Last 50 years Remove constraint Publication Year Range: Last 50 years
287 results on '"Loussouarn, Delphine"'

Search Results

2. Deep Learning for Detecting BRCA Mutations in High-Grade Ovarian Cancer Based on an Innovative Tumor Segmentation Method From Whole Slide Images

3. Diagnostic des sarcomes utérins et tumeurs mésenchymateuses utérines rares à potentiel de malignité. Référentiels du Groupe Sarcome Français et des Tumeurs Rares Gynécologiques

6. Phenotypic discordance between primary and metastatic breast cancer in the large-scale real-life multicenter French ESME cohort

7. Pineoblastoma segregates into molecular sub-groups with distinct clinico-pathologic features: a Rare Brain Tumor Consortium registry study

8. Deep Learning Methodologies Applied to Digital Pathology in Prostate Cancer: A Systematic Review

10. STING-dependent paracriny shapes apoptotic priming of breast tumors in response to anti-mitotic treatment

12. CD8+ T cell-mediated endotheliopathy is a targetable mechanism of neuro-inflammation in Susac syndrome

14. Figure S6 from Efficient Mitochondrial Glutamine Targeting Prevails Over Glioblastoma Metabolic Plasticity

15. Supplementary Tables from Efficient Mitochondrial Glutamine Targeting Prevails Over Glioblastoma Metabolic Plasticity

17. Diagnostic des sarcomes utérins et tumeurs mésenchymateuses utérines rares à potentiel de malignité. Référentiels du Groupe Sarcome Français et des Tumeurs Rares Gynécologiques

21. Uterine sarcomas and rare uterine mesenchymal tumors with malignant potential. Diagnostic guidelines of the French Sarcoma Group and the Rare Gynecological Tumors Group

22. Mise à jour 2014 des recommandations du GEFPICS pour l’évaluation du statut HER2 dans les cancers du sein en France

23. Recommandations du GEFPICS concernant la phase pré-analytique pour l’évaluation de HER2 et des récepteurs hormonaux dans le cancer du sein : mise à jour 2014

24. A Multigene Signature Associated with Progression-Free Survival after Treatment for IDH Mutant and 1p/19q Codeleted Oligodendrogliomas.

25. Prognostic value of hPG80 (circulating progastrin) in IDH-wild type glioblastoma treated with radio-chemotherapy.

26. Pharmacological targeting of apelin impairs glioblastoma growth

27. Tumor cells with neuronal intermediate progenitor features define a subgroup of 1p/19q co‐deleted anaplastic gliomas

29. A Convenient Route to New (Radio)Fluorinated and (Radio)Iodinated Cyclic Tyrosine Analogs

31. A phase II randomised study of preoperative trastuzumab alone or combined with everolimus in patients with early HER2-positive breast cancer and predictive biomarkers (RADHER trial)

32. Prognostic Relevance of Histomolecular Classification of Diffuse Adult High-Grade Gliomas with Necrosis

36. Supplementary_methods_1 – Supplemental material for Identification of an immune-suppressed subtype of feline triple-negative basal-like invasive mammary carcinomas, spontaneous models of breast cancer

38. Validation of tumor-associated macrophage ferritin light chain as a prognostic biomarker in node-negative breast cancer tumors: A multicentric 2004 national PHRC study

41. Pineoblastoma segregates into molecular sub-groups with distinct clinico-pathologic features: a Rare Brain Tumor Consortium registry study

42. Combined chemotherapy and allogeneic human Vγ9Vδ2 T lymphocyte-immunotherapies efficiently control the development of human epithelial ovarian cancer cells in vivo

43. Additional file 18: of Identification of three subtypes of triple-negative breast cancer with potential therapeutic implications

44. Additional file 29: of Identification of three subtypes of triple-negative breast cancer with potential therapeutic implications

45. Additional file 5: of Identification of three subtypes of triple-negative breast cancer with potential therapeutic implications

46. Additional file 3: of Identification of three subtypes of triple-negative breast cancer with potential therapeutic implications

47. Additional file 4: of Identification of three subtypes of triple-negative breast cancer with potential therapeutic implications

48. Additional file 9: of Identification of three subtypes of triple-negative breast cancer with potential therapeutic implications

49. Additional file 6: of Identification of three subtypes of triple-negative breast cancer with potential therapeutic implications

50. Additional file 7: of Identification of three subtypes of triple-negative breast cancer with potential therapeutic implications

Catalog

Books, media, physical & digital resources